|
C11ORF84 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.84550169485465E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.77169999963034E-07 |
| Normal-vs-Stage2 |
5.437500E-03 |
| Normal-vs-Stage3 |
3.21130000002778E-06 |
| Normal-vs-Stage4 |
2.723800E-02 |
| Stage1-vs-Stage2 |
2.495400E-01 |
| Stage1-vs-Stage3 |
7.597600E-04 |
| Stage1-vs-Stage4 |
1.685840E-01 |
| Stage2-vs-Stage3 |
5.568000E-02 |
| Stage2-vs-Stage4 |
4.523800E-01 |
| Stage3-vs-Stage4 |
4.420600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.74940070710272E-11 |
| Normal-vs-AfricanAmerican |
2.572200E-04 |
| Normal-vs-Asian |
2.145600E-02 |
| Caucasian-vs-AfricanAmerican |
1.243390E-01 |
| Caucasian-vs-Asian |
1.183960E-01 |
| AfricanAmerican-vs-Asian |
3.313600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.28670000210107E-08 |
| Normal-vs-Female |
3.34880012609062E-10 |
| Male-vs-Female |
2.138700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.3923999999953E-05 |
| Normal-vs-Extreme_Weight |
8.61049999967278E-07 |
| Normal-vs-Obese |
7.10499999945213E-07 |
| Normal-vs-Extreme_Obese |
8.363900E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.471570E-01 |
| Normal_Weight-vs-Obese |
6.972800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.086000E-01 |
| Extreme_Weight-vs-Obese |
1.987010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.209000E-01 |
| Obese-vs-Extreme_Obese |
6.106000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.14759999999492E-05 |
| Normal-vs-Age(41-60Yrs) |
7.53220041893599E-10 |
| Normal-vs-Age(61-80Yrs) |
6.11889999779791E-08 |
| Normal-vs-Age(81-100Yrs) |
9.419200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.392700E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.600280E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.85550000000912E-05 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.403500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.622700E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.078280E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.41169997913693E-09 |
| Normal-VS-Type2 PRCC |
2.115600E-03 |
| Normal-VS-KIRP CIMP |
1.73039999995517E-06 |
| Normal-VS-Unclassified PRCC |
3.61290000000514E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.691590E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.76463999999044E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
3.142200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.62447832963153E-12 |
| Type2 PRCC-VS-Unclassified PRCC |
1.880380E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.45460343559512E-11 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.20479999999412E-05 |
| Normal-vs-N1 |
1.50113999999313E-05 |
| Normal-vs-N2 |
7.591800E-02 |
| N0-vs-N1 |
1.383250E-03 |
| N0-vs-N2 |
7.924500E-03 |
| N1-vs-N2 |
9.839200E-01 |
|
|
